Angela Pollard, MD
Obstetrics/Gynecology · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 29
- 6 carriers
- Office
- 1
Offices
1 location · UCSF Health Medical Foundation · 40 clinicians in this group
Looking this up.
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
29 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Pollard’s office at (650) 701-1882 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
29 of 29 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$12,743
Medicare paid this office $12,743 for 59 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 36 | $5,485 | $112 |
| Complete ultrasound scan of pelvis | 11 | $1,628 | $109 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 29 | $1,389 | $48 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 23 | $1,319 | $57 |
| Short return visit (20+ min) | 11 | $898 | $75 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Who their Medicare patients are
59 Original Medicare patients in 2024. Average age 70 · Women 100% · Health risk score 0.67. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 59%.
The office billed $64,027, Medicare allowed $16,242 and paid $12,743; for 153 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 59 | 153 | 70 | 0.67 | $64,027 | $12,743 |
| 2023 | 65 | 140 | 71 | 0.63 | $62,996 | $10,273 |
| 2022 | 88 | 198 | 72 | 0.71 | $77,856 | $16,482 |
| 2021 | 66 | 143 | 70 | 0.67 | $46,401 | $11,755 |
| 2020 | 71 | 179 | 70 | 0.82 | $53,249 | $15,940 |
| 2019 | 57 | 145 | 69 | 0.84 | $48,331 | $15,481 |
| 2018 | 48 | 100 | 69 | 0.75 | $17,781 | $9,278 |
| 2017 | 130 | 275 | 72 | 0.76 | $46,939 | $21,199 |
| 2016 | 145 | 321 | 72 | 0.71 | $44,458 | $28,274 |
| 2015 | 69 | 135 | 70 | 0.66 | $19,407 | $13,659 |
| 2014 | 49 | 113 | 68 | 0.83 | $28,078 | $10,741 |
| 2013 | 68 | 166 | 68 | 0.89 | $18,148 | $13,865 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 25 | $3,503 | $106 |
| Complete ultrasound scan of pelvis | 14 | $1,223 | $82 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 21 | $1,068 | $51 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 24 | $1,044 | $43 |
| Short return visit (20+ min) | 12 | $712 | $59 |
2022: 6 services
| Return visit (30+ min) | 23 | $3,219 | $107 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 37 | $2,082 | $56 |
| Complete ultrasound scan of pelvis | 12 | $1,736 | $109 |
| New patient visit (30+ min) | 16 | $1,470 | $92 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 30 | $1,465 | $49 |
| Short return visit (20+ min) | 11 | $1,282 | $85 |
2021: 3 services
| Return visit (30+ min) | 29 | $3,771 | $108 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 28 | $1,561 | $56 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 27 | $1,309 | $48 |
2020: 7 services
| Return visit (30+ min) | 56 | $7,202 | $92 |
| Complete ultrasound scan of pelvis | 17 | $1,899 | $105 |
| New patient visit (45+ min) | 11 | $1,298 | $118 |
| Short return visit (20+ min) | 14 | $946 | $63 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 14 | $767 | $55 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 15 | $714 | $48 |
| Urinalysis, manual test | 15 | $52 | $3 |
2019: 3 services
| Return visit (30+ min) | 36 | $5,459 | $96 |
| New patient visit (45+ min) | 16 | $2,380 | $149 |
| Short return visit (20+ min) | 20 | $1,554 | $65 |
2018: 3 services
| Return visit (30+ min) | 33 | $4,053 | $88 |
| Complete ultrasound scan of pelvis | 13 | $1,707 | $107 |
| Short return visit (20+ min) | 12 | $718 | $60 |
2017: 5 services
| Return visit (30+ min) | 86 | $10,444 | $91 |
| Short return visit (20+ min) | 38 | $2,684 | $61 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 42 | $2,242 | $53 |
| Complete ultrasound scan of pelvis | 14 | $1,735 | $108 |
| Urinalysis, manual test | 16 | $62 | $3 |
2016: 8 services
| Return visit (30+ min) | 46 | $5,312 | $97 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | $5,081 | $137 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 58 | $3,204 | $55 |
| Short return visit (20+ min) | 38 | $2,958 | $63 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 55 | $2,480 | $45 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 11 | $2,191 | $199 |
| Complete ultrasound scan of pelvis | 17 | $2,053 | $108 |
| New patient visit (30+ min) | 11 | $1,108 | $101 |
2015: 4 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 33 | $4,520 | $137 |
| Return visit (30+ min) | 15 | $1,811 | $101 |
| Short return visit (20+ min) | 17 | $1,436 | $68 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 21 | $1,159 | $55 |
2014: 4 services
| Return visit (30+ min) | 24 | $2,460 | $91 |
| Short return visit (20+ min) | 14 | $1,108 | $55 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 15 | $819 | $55 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 16 | $719 | $45 |
2013: 5 services
| Return visit (30+ min) | 36 | $3,754 | $89 |
| Complete ultrasound scan of pelvis | 13 | $1,921 | $128 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 29 | $1,625 | $56 |
| New patient visit (30+ min) | 12 | $1,204 | $100 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 25 | $1,131 | $45 |
Medicaid work
$0 in 2021
Medicaid paid $0 for 93 billed services this clinician did in 2021, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 93 | $0 |
| 2021 | 93 | 1 | 18 | $0 |
| 2020 | 198 | 2 | 22 | $368 |
| 2019 | 23 | 1 | 16 | $0 |
See the largest Medicaid services in earlier years
2020
| ANTEPARTUM CARE ONLY 4-6 VISITS | 82 | $363 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 116 | $5 |
2019
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 23 | $0 |
Drugs they prescribed that Part D paid
$16,616
Pharmacies billed $16,616 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 131) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
88 generic and fewer than 11 brand-name prescriptions · $16,616 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol (Twice Weekly) | 24 | $2,255 | $94 |
| Progesterone | 19 | $1,236 | $65 |
Year by year
| 2024 | 131 | 38 | 0% (0) | None | $16,616 |
| 2023 | 108 | 42 | None | None | $12,542 |
| 2022 | 169 | 50 | None | None | $21,677 |
| 2021 | 150 | 37 | 0% (0) | None | $14,332 |
| 2020 | 216 | 46 | None | 30% | $18,830 |
| 2019 | 264 | 51 | None | 28% | $18,030 |
| 2018 | 277 | 67 | None | 26% | $19,361 |
| 2017 | 266 | 72 | None | 24% | $21,913 |
| 2016 | 261 | 59 | None | 23% | $14,461 |
| 2015 | 233 | 52 | None | None | $18,549 |
| 2014 | 258 | 58 | None | None | $17,244 |
| 2013 | 197 | 45 | None | 21% | $7,907 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Estradiol (Twice Weekly) | 17 | $1,934 | $114 |
| Progesterone | 13 | $496 | $38 |
2022: 5 drugs
| Estring | 12 | $6,093 | $508 |
| Premarin | 11 | $5,321 | $484 |
| Progesterone | 24 | $1,605 | $67 |
| Estradiol | 16 | $313 | $20 |
| Zolpidem | 11 | $77 | $7 |
2021: 4 drugs
| Estradiol (Twice Weekly) | 19 | $2,975 | $157 |
| Estradiol | 11 | $1,431 | $130 |
| Progesterone | 12 | $685 | $57 |
| Zolpidem | 18 | $198 | $11 |
2020: 4 drugs
| Estradiol (Twice Weekly) | 44 | $4,202 | $96 |
| Progesterone | 15 | $417 | $28 |
| Nitrofurantoin Mono-Macro | 11 | $279 | $25 |
| Zolpidem | 25 | $165 | $7 |
2019: 5 drugs
| Estradiol | 53 | $4,854 | $92 |
| Nitrofurantoin Mono-Macro | 24 | $521 | $22 |
| Levothyroxine | 14 | $281 | $20 |
| Fluconazole | 13 | $199 | $15 |
| Zolpidem | 19 | $46 | $2 |
2018: 7 drugs
| Estradiol | 39 | $3,662 | $94 |
| Progesterone | 16 | $1,053 | $66 |
| Synthroid | 14 | $795 | $57 |
| Levothyroxine | 13 | $307 | $24 |
| Irbesartan | 11 | $247 | $22 |
| Alendronate | 17 | $104 | $6 |
| Ciprofloxacin | 15 | $85 | $6 |
2017: 7 drugs
| Estrace | 12 | $3,474 | $289 |
| Estradiol | 14 | $1,209 | $86 |
| Progesterone | 21 | $1,155 | $55 |
| Menest | 13 | $865 | $67 |
| Synthroid | 14 | $763 | $54 |
| Levothyroxine | 22 | $421 | $19 |
| Sulfamethoxazole-Trimethoprim | 11 | $244 | $22 |
2016: 7 drugs
| Estradiol | 22 | $1,211 | $55 |
| Progesterone | 21 | $1,153 | $55 |
| Menest | 12 | $759 | $63 |
| Synthroid | 11 | $524 | $48 |
| Levothyroxine | 19 | $235 | $12 |
| Sulfamethoxazole-Trimethoprim | 13 | $183 | $14 |
| Atorvastatin | 13 | $86 | $7 |
2015: 6 drugs
| Vagifem | 14 | $3,525 | $252 |
| Estradiol | 18 | $1,242 | $69 |
| Menest | 13 | $1,010 | $78 |
| Progesterone | 11 | $519 | $47 |
| Levothyroxine | 24 | $301 | $13 |
| Sulfamethoxazole-Trimethoprim | 12 | $184 | $15 |
2014: 6 drugs
| Vivelle-Dot | 13 | $1,650 | $127 |
| Menest | 17 | $801 | $47 |
| Levothyroxine | 19 | $273 | $14 |
| Estradiol | 25 | $180 | $7 |
| Sulfamethoxazole-Trimethoprim | 16 | $159 | $10 |
| Fluconazole | 14 | $84 | $6 |
2013: 4 drugs
| Vivelle-Dot | 14 | $1,161 | $83 |
| Menest | 24 | $771 | $32 |
| Estradiol | 23 | $170 | $7 |
| Fluconazole | 15 | $73 | $5 |
Money from drug and device companies
$756 in 2025
| 2025 | 11 | 25 | None | $756 |
| 2024 | 13 | 47 | None | $744 |
| 2023 | 17 | 58 | None | $1,191 |
| 2022 | 9 | 34 | None | $633 |
| 2021 | 4 | 8 | None | $163 |
| 2020 | 8 | 30 | None | $561 |
| 2019 | 13 | 48 | $4,000 | $4,783 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Veozah | $295 | 7 payments
|
| Novo Nordisk | Wegovy | $119 | 1 payment
|
| Mayne Pharma Commercial | None | $61 | 4 payments
|
| Pfizer | Abrysvo | $53 | 3 payments
|
| Exact Sciences | Cologuard Collection Kit | $47 | 2 payments
|
| Organon | Nexplanon | $45 | 2 payments
|
See all 25 published payments
| Sumitomo Pharma America | Meals · 2025-12-16 | Myfembree | $19 |
| Organon | Meals · 2025-12-05 | Nexplanon | $21 |
| Mayne Pharma Commercial | Meals · 2025-11-11 | None | $12 |
| Astellas Pharma US | Meals · 2025-11-10 | Veozah | $34 |
| Mayne Pharma Commercial | Meals · 2025-11-07 | None | $29 |
| Exact Sciences | Meals · 2025-10-27 | None | $18 |
| Pfizer | Meals · 2025-10-14 | Abrysvo | $17 |
| Mayne Pharma Commercial | Meals · 2025-09-30 | None | $11 |
| Astellas Pharma US | Meals · 2025-09-24 | Veozah | $27 |
| Pfizer | Meals · 2025-08-25 | Abrysvo | $18 |
| Mayne Pharma Commercial | Meals · 2025-07-31 | None | $9 |
| Astellas Pharma US | Meals · 2025-07-29 | Veozah | $30 |
| Pfizer | Meals · 2025-06-25 | Abrysvo | $18 |
| Astellas Pharma US | Meals · 2025-06-18 | Veozah | $32 |
| Millicent US | Meals · 2025-05-27 | Femlyv | $24 |
| Ethicon US | Meals · 2025-05-07 | Echelon Flex | $36 |
| Novo Nordisk | Meals · 2025-04-17 | Wegovy | $119 |
| Sumitomo Pharma America | Meals · 2025-04-15 | Gemtesa | $15 |
| Organon | Meals · 2025-04-03 | Nexplanon | $24 |
| Astellas Pharma US | Meals · 2025-03-26 | Veozah | $26 |
| Medtronic | Meals · 2025-03-13 | Rapidvac | $18 |
| Astellas Pharma US | Meals · 2025-02-25 | Veozah | $20 |
| Exact Sciences | Meals · 2025-02-10 | Cologuard Collection Kit | $29 |
| Astellas Pharma US | Meals · 2025-01-30 | Veozah | $125 |
| Biogen | Meals · 2025-01-14 | Zurzuvae | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $744
| Mayne Pharma Commercial | None | $308 | 26 payments
|
| Astellas Pharma US | Veozah | $101 | 4 payments
|
| Lilly USA | Zepbound | $74 | 4 payments
|
| Biogen | Zurzuvae | $46 | 2 payments
|
| Organon | Nexplanon | $45 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $44 | 2 payments
|
| CooperSurgical | Paragard T 380a | $26 | 1 payment
|
| Evofem Biosciences | None | $23 | 1 payment
|
| Novo Nordisk | Wegovy | $19 | 1 payment
|
| Pfizer | Abrysvo | $17 | 1 payment
|
| Sumitomo Pharma America | Myfembree | $14 | 1 payment
|
| Bausch Health US | Aplenzin | $13 | 1 payment
|
| Meditrina | None | $13 | 1 payment
|
2023: $1,191
| Mayne Pharma Commercial | Nextstellis | $537 | 35 payments
|
| Minerva Surgical | None | $203 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $131 | 6 payments
|
| Pfizer | Myfembree | $39 | 2 payments
|
| Novo Nordisk | Saxenda | $37 | 2 payments
|
| Pacira Pharmaceuticals | Exparel | $29 | 1 payment
|
| Abbvie | Ubrelvy | $27 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kyleena | $24 | 1 payment
|
| Ascend Therapeutics US | Estrogel | $23 | 1 payment
|
| Shield Therapeutics | Accrufer | $22 | 1 payment
|
| Avion Pharmaceuticals | Balcoltra | $21 | 1 payment
|
| Ethicon US | Ethicon | $20 | 1 payment
|
| Sumitomo Pharma America | Myfembree | $17 | 1 payment
|
| Astellas Pharma US | Veozah | $17 | 1 payment
|
| Bausch Health US | Aplenzin | $16 | 1 payment
|
| Becton Dickinson and | Bd Onclarity | $16 | 1 payment
|
| CooperSurgical | Paragard T 380a | $14 | 1 payment
|
2022: $633
| Hologic | Acessa Provu System | $140 | 1 payment
|
| TherapeuticsMD | Annovera | $132 | 17 payments
|
| Abbvie | Lo Loestrin Fe | $96 | 4 payments
|
| Organon | Nexplanon | $72 | 3 payments
|
| Myovant Sciences | Myfembree | $61 | 3 payments
|
| Mayne Pharma | None | $47 | 2 payments
|
| Pfizer | Myfembree | $36 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $25 | 1 payment
|
| ASCEND Therapeutics US | Estrogel | $24 | 1 payment
|
2021: $163
| AbbVie | Lo Loestrin Fe | $104 | 4 payments
|
| Pfizer | Myfembree | $28 | 2 payments
|
| TherapeuticsMD | Annovera | $17 | 1 payment
|
| Evofem Biosciences | Phexxi | $14 | 1 payment
|
2020: $561
| AbbVie | Oriahnn | $294 | 18 payments
|
| CooperSurgical | Paragard | $75 | 2 payments
|
| Avion Pharmaceuticals | Balcoltra | $68 | 4 payments
|
| Allergan | Ubrelvy | $42 | 2 payments
|
| Merck Sharp & Dohme | None | $22 | 1 payment
|
| Lupin | Solosec | $22 | 1 payment
|
| TherapeuticsMD | Annovera | $22 | 1 payment
|
| Exeltis USA | Nuvessa | $16 | 1 payment
|
2019: $4,783
| Intuitive Surgical | Da Vinci Surgical System | $4,000 | 1 payment
|
| AbbVie | Orilissa | $387 | 21 payments
|
| Vertical Pharmaceuticals | Divigel | $95 | 6 payments
|
| Roche Diagnostics | Rs Harmony Test Related Products | $86 | 4 payments
|
| TherapeuticsMD | Imvexxy | $68 | 4 payments
|
| Pfizer | Premarin | $39 | 2 payments
|
| Allergan | Lo Loestrin Fe | $24 | 1 payment
|
| Lupin | Solosec | $17 | 1 payment
|
| Avion Pharmaceuticals | Prenate Mini | $16 | 1 payment
|
| Merck Sharp & Dohme | None | $13 | 1 payment
|
| ASCEND Therapeutics US | Estrogel | $13 | 1 payment
|
| AMAG Pharmaceuticals | Intrarosa | $13 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $12 | 1 payment
|
Professional record
- NPI
- 1467463190
- Licence
- CA A065598
- Trained
- University of California, San Diego School of Medicine, 1994
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 700 W. Parr Ave Ste I, Los Gatos, CA, 95032
- NPI first listed
- 2006-08-10
- NPI last updated
- 2015-04-16
This is when the NPI record was last certified, not a medical board exam.